---
title: "Stopping NMN or NR safely | HealthRX.com"
description: "No validated taper or stopping protocol exists for NMN or NR. This page covers what trials reported during dosing and what the evidence shows."
url: https://healthrx.com/nad-nmn/discontinuation-protocol
publisher: HealthRX.com
---


HealthRX.com

No tested taper exists for NMN or NR

[Print or save as PDF](https://healthrx.com/printables/nad-nmn/discontinuation-protocol?print=1)

Key numbers

- 12 weeks Longest fixed dosing course in the cited trials; no taper was tested Source: [pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37068054/), as cited Nov 8, 2026
- 1,250 mg/day Top NMN dose in fixed-dose trials; NR went up to 3,000 mg/day Source: [pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/36002548/), as cited Nov 8, 2026
- 1,250 mg Highest NMN dose tested; no severe adverse events in 31 adults over up to 4 weeks Source: [pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/36002548/), as cited Nov 8, 2026
- 1,000 mg NR dose in 40 obese men over 12 weeks; no serious adverse events Source: [pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/29992272/), as cited Nov 8, 2026

[See the public record for NMN (nicotinamide mononucleotide)](https://healthrx.com/data/nmn-nicotinamide-mononucleotide)

HealthRX.com quick answer. No validated taper or stopping protocol exists for NMN or NR: the human trials dosed people for fixed periods and did not test a taper schedule. During dosing, blood NAD+ rose, and the trials reported no serious adverse events [1][2][3][4][5].

At a glance

- What they are / Oral dietary supplements; neither is FDA-approved as a drug [6]
- Doses studied / NMN 250 to 1,250 mg/day and NR 1,000 to 3,000 mg/day in human trials [7][3][8][4]
- Reported while dosing / Blood NAD+ rose; some trials reported mild adverse events, others no serious or severe events [1][3][4]
- Longest dosing in trials / About 12 weeks [9]
- Human drug-interaction studies / None found in a PubMed search [9]
- Clinical benefit / Unproven; 2025 meta-analyses found no significant effect on strength, gait speed or most metabolic outcomes [10][11]

## Is there a tested way to stop?

No taper schedule or stopping protocol for NMN or NR has been validated. The trials cited on this page gave fixed courses of dosing, from 21 days to 12 weeks, and reported results from the dosing period [3][4][5][9]. None of them tested tapering against stopping at once.

What people on Reddit report

Accounts from people who stopped NMN or NR after dizziness, vision or cognitive symptoms, and what they noticed afterward. Experiences differ, and none of them followed a tested taper.

Murky_Professor_2649 · NMN

I had dizzinesss and lightheadedness too, felt pressure in my head and behind my eyes. I stopped taking it, and I'm sorry I ever tried NMN.

Reports dizziness and lightheadedness that eased after stopping NMN, while also taking TMG.

[Read the source discussion](https://www.reddit.com/r/NMN/comments/1afffgc/stopping_nmn_for_the_moment_due_to_dizziness/)

Otherwise_Proposal87 · NMN

I took it for 3 months without any side effect but from fourth month , my vision blurred , I feel like I am always drunk , my cognitive function also took hit . I stopped a week before but I the improvement is marginal.

Reports vision and cognitive changes that started months into NMN use; says improvement after stopping has been small.

[Read the source discussion](https://www.reddit.com/r/NMN/comments/1afffgc/stopping_nmn_for_the_moment_due_to_dizziness/)

philly_kk · NMN

It's month three of stopping for me and symptoms don't seem to be going away.

Reports that symptoms have persisted for months after stopping NMN.

[Read the source discussion](https://www.reddit.com/r/NMN/comments/1afffgc/stopping_nmn_for_the_moment_due_to_dizziness/)

Questions worth asking

Choose the questions you want to keep Which symptoms should make me contact my prescriber before I stop NMN or NR? Should my blood pressure be checked if I notice changes after stopping NMN or NR? Is there any test that would show my NAD+ level after I stop taking NMN or NR? Should I tell my pharmacist about other supplements I take alongside NMN or NR? What follow-up would my prescriber suggest if symptoms continue after I stop? Could my prescriber review whether another cause could explain any symptoms I notice?

## What the trials reported while people were taking it

- NMN 250 mg/day for 12 weeks in 30 healthy adults raised whole-blood NAD+ with no abnormalities on physiological or laboratory testing [1].
- NMN 300, 600 or 900 mg/day for 60 days in 80 middle-aged adults raised blood NAD+ in every NMN group, highest at 600 and 900 mg, with no safety issues reported [2].
- NMN 1,250 mg once daily for up to 4 weeks in 31 adults aged 20 to 65 caused no severe adverse events and no changes beyond normal physiological variation [4].
- NR 500 mg twice daily in a 6-week crossover study of 24 completers was well tolerated; 7 participants reported 14 mild events (nausea, flushing, leg cramps, bruising) and there were no serious events [3].
- NR 1,000 mg twice daily for 12 weeks in 40 obese men caused no serious adverse events and normal safety blood tests [5].

## What benefit would be lost

Any benefit is unproven. A 10-week randomized trial in postmenopausal women with [prediabetes](https://healthrx.com/conditions-prediabetes/diagnosis-algorithm) who were overweight or obese (25 completers) reported higher insulin-stimulated glucose disposal after NMN, with no change after placebo. It was a small study, and it does not show what happens after stopping [7].

In a 21-day study of 12 men aged 70 to 80, NR did not raise muscle NAD+, although a marker of NAD+ synthesis doubled, and mitochondrial respiration, [grip strength](https://healthrx.com/labs-grip-strength/what-it-measures) and insulin sensitivity were unchanged [12]. A 2025 meta-analysis of randomized trials in [older adults](https://healthrx.com/nad-nmn/older-adult-dosing) found NMN had no significant effect on skeletal muscle index, handgrip strength, gait speed or the 5-times chair stand [10]. A second 2025 meta-analysis of 12 studies and 513 participants found blood NAD rose but most clinical outcomes did not differ from control [11].

## Unknowns that affect stopping NMN or NR

Long-term safety beyond about 12 weeks of dosing is lacking, and the trials were small, from 12 to 140 participants [9]. Pregnancy, breastfeeding, children, and people with cancer or kidney or liver disease were not studied in the cited trials, so safety in these groups is unknown [9]. No human [drug-interaction](https://healthrx.com/nad-nmn/drug-drug-interactions) studies of NMN or NR were found in a PubMed search [9].

## How NMN and NR are classified as supplements

NMN and NR are sold in the US as oral dietary supplements; neither is FDA-approved to treat aging or any disease [6]. NMN is not banned. Reports of FDA's response to a citizen petition, dated 2025-09-29, say FDA concluded NMN is not excluded from the dietary supplement definition, so it may be lawfully marketed subject to new-dietary-ingredient notification rules [6]. For NR, FDA's 2016 letter on GRAS Notice 000635 said it had no questions about the company's own GRAS conclusion and had not made its own GRAS determination [13].

Check what you know

Think you have it? Try 3 quick questions and see what the article says.

1. According to the article, has a taper or stopping protocol for NMN or NR been validated?

Question 1 of 3

Score: 0 right, 0 of 3 answered

Printable question sheet

NMN or NR stopping questions for your prescriber or pharmacist

Use this sheet before you stop taking NMN or NR supplements. Fill in your product details, bring the questions to your prescriber or pharmacist, and track any changes after your last dose. No stopping schedule for these supplements has been tested.

[Open the fill-in sheet](https://healthrx.com/printables/nad-nmn/discontinuation-protocol) Fill it in, print it or save it as a PDF. No sign-up.

Frequently asked questions

Is it dangerous to stop NMN or NR suddenly?

No stopping or taper schedule has been tested in the cited trials, so they do not describe what happens after the last dose. During dosing, some trials reported mild adverse events and others reported no serious or severe events [3][4][5].

How long does NAD+ stay elevated after the last dose?

In the trials, blood NAD+ rose with daily NMN or NR and stayed elevated while dosing continued [1][2]. The time course after the last dose is not established.

Do I need to taper NMN or NR?

No taper schedule has been validated. The published trials used fixed daily doses, from NMN 250 mg/day to 1,250 mg/day and NR 1,000 mg/day to 3,000 mg/day [7][4][3][8].

Will I lose metabolic benefits when I stop?

NMN improved insulin-stimulated glucose disposal in a 25-person trial [7], but NR did not raise muscle NAD+ or change muscle function in 12 older men [12], NR 2,000 mg/day did not improve insulin sensitivity in 40 obese men [5], and 2025 meta-analyses found no significant effect on strength, gait speed or most metabolic measures [10][11].

Is NMN legal to buy in the US?

Reports of FDA's 2025-09-29 response to a citizen petition say FDA concluded NMN is not excluded from the dietary supplement definition, subject to new-dietary-ingredient notification rules [6]. Neither NMN nor NR is FDA-approved as a drug [6].

Reader questions

What people actually ask

Short answers drawn from the sources this article cites.

What if I stop taking NMN?

No validated stopping protocol exists, and the trials did not test stopping. Any benefit is unproven and the research does not show what happens after stopping. The one metabolic trial reporting gains was a 10-week study of 25 completers with prediabetes.

Who should not take NMN?

Pregnancy, breastfeeding, children, and people with cancer or kidney or liver disease were not studied in the cited trials, so safety in these groups is unknown. The longest dosing in trials was about 12 weeks, and long-term safety beyond that is lacking.

How long does it take for NMN to get out of your system?

How long NMN or NR stays in the body after the last dose is not established. No stopping study has measured it. In the trials, blood NAD+ rose with daily dosing and stayed elevated while dosing continued.

What not to mix with NMN?

No human drug-interaction studies of NMN or NR were found in a PubMed search, so which substances interact with them is not established. Trials dosed NMN at 250 to 1,250 mg/day and NR at 1,000 to 3,000 mg/day.

References

Show all 14 references Hide references

1. Okabe K, Yaku K, Uchida Y, Fukamizu Y, Sato T, Sakurai T, et al. [Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects](https://pubmed.ncbi.nlm.nih.gov/35479740/). Front Nutr. 2022;9:868640.
2. Yi L, Maier AB, Tao R, Lin Z, Vaidya A, Pendse S, et al. [The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial](https://pubmed.ncbi.nlm.nih.gov/36482258/). Geroscience. 2023;45(1):29-43.
3. Martens CR, Denman BA, Mazzo MR, Armstrong ML, Reisdorph N, McQueen MB, et al. [Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults](https://pubmed.ncbi.nlm.nih.gov/29599478/). Nat Commun. 2018;9(1):1286.
4. Fukamizu Y, Uchida Y, Shigekawa A, Sato T, Kosaka H, Sakurai T. [Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women](https://pubmed.ncbi.nlm.nih.gov/36002548/). Sci Rep. 2022;12(1):14442.
5. Dollerup OL, Christensen B, Svart M, Schmidt MS, Sulek K, Ringgaard S, et al. [A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects](https://pubmed.ncbi.nlm.nih.gov/29992272/). Am J Clin Nutr. 2018;108(2):343-353.
6. Regulations.gov, FDA docket FDA-2023-P-0872: FDA response to citizen petition on NMN. [Regulations.gov document FDA-2023-P-0872-2754](https://www.regulations.gov/document/FDA-2023-P-0872-2754)
7. Yoshino M, Yoshino J, Kayser BD, Patti GJ, Franczyk MP, Mills KF, et al. [Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women](https://pubmed.ncbi.nlm.nih.gov/33888596/). Science. 2021;372(6547):1224-1229.
8. Berven H, Kverneng S, Sheard E, Søgnen M, Af Geijerstam SA, Haugarvoll K, et al. [NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson's disease](https://pubmed.ncbi.nlm.nih.gov/38016950/). Nat Commun. 2023;14(1):7793.
9. Freeberg KA, Udovich CC, Martens CR, Seals DR, Craighead DH. [Dietary Supplementation With NAD+-Boosting Compounds in Humans: Current Knowledge and Future Directions](https://pubmed.ncbi.nlm.nih.gov/37068054/). J Gerontol A Biol Sci Med Sci. 2023;78(12):2435-2448.
10. Prokopidis K, Moriarty F, Bahat G, McLean J, Church DD, Patel HP. [The Effect of Nicotinamide Mononucleotide and Riboside on Skeletal Muscle Mass and Function: A Systematic Review and Meta-Analysis](https://pubmed.ncbi.nlm.nih.gov/40275690/). J Cachexia Sarcopenia Muscle. 2025;16(3):e13799.
11. Zhang J, Poon ET, Wong SH. [Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis on randomized controlled trials](https://pubmed.ncbi.nlm.nih.gov/39116016/). Crit Rev Food Sci Nutr. 2025;65(22):4382-4400.
12. Elhassan YS, Kluckova K, Fletcher RS, Schmidt MS, Garten A, Doig CL, et al. [Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures](https://pubmed.ncbi.nlm.nih.gov/31412242/). Cell Rep. 2019;28(7):1717-1728.e6.
13. [Agency Response Letter GRAS Notice No. GRN 000635 | FDA](https://www.fda.gov/food/gras-notice-inventory/agency-response-letter-gras-notice-no-grn-000635).
14. Reddit participants. [Stopping NMN for the moment due to dizziness (r/NMN)](https://www.reddit.com/r/NMN/comments/1afffgc/stopping_nmn_for_the_moment_due_to_dizziness/). Accessed 2026-11-10.

Next in this cluster

Related reading

- [nicotinamide mononucleotide NMN caffeine](https://healthrx.com/supplements-nad-nmn/with-caffeine)
- [nicotinamide mononucleotide CoQ10 with NMN](https://healthrx.com/supplements-nad-nmn/with-coq10)
- [nicotinamide mononucleotide NR calcium interaction](https://healthrx.com/supplements-nad-nmn/with-calcium)
- [nicotinamide mononucleotide NMN 5-HTP interaction](https://healthrx.com/supplements-nad-nmn/with-5-htp)
- [nicotinamide mononucleotide NMN and NR Drug Interactions: A Complete Clinical Profile](https://healthrx.com/nad-nmn/drug-drug-interactions)
- [nicotinamide mononucleotide NMN evidence](https://healthrx.com/nad-nmn/evidence-base-graded)
- [nicotinamide mononucleotide NMN food interactions](https://healthrx.com/nad-nmn/food-supplement-interactions)
- [nicotinamide mononucleotide NMN future formulations](https://healthrx.com/nad-nmn/future-pipeline)
- [nicotinamide mononucleotide NMN/NR Geriatric Dosing](https://healthrx.com/nad-nmn/geriatric-dosing)
- [nicotinamide mononucleotide NMN/NR (Nicotinamide Mononucleotide/Riboside) Geriatric (65+) Monitoring](https://healthrx.com/nad-nmn/geriatric-monitoring)
- [nicotinamide mononucleotide NMN geriatric safety](https://healthrx.com/nad-nmn/geriatric-safety)
- [nicotinamide mononucleotide NMN hair and skin](https://healthrx.com/nad-nmn/hair-skin-impact)
- [nicotinamide mononucleotide NMN finasteride interaction](https://healthrx.com/interactions-nad-nmn/with-finasteride)
- [nicotinamide mononucleotide NMN and NR Side Effects](https://healthrx.com/side-effects-v2-nad-nmn/permanent-side-effects)

![stopping nmn nr: weekly pill organizer and water glass on a bedside table at dawn](https://zwulxpn434zaufgz.public.blob.vercel-storage.com/page-images/nad-nmn/discontinuation-protocol.webp)

No tested taper exists for NMN or NR, so stopping decisions are best discussed with a clinician. Full NMN discontinuation guide and sources at [healthrx.com/nad-nmn](https://healthrx.com/nad-nmn).

> Compounded drugs are not FDA-approved or reviewed by FDA for safety, effectiveness, or quality before marketing.
